FLT3 inhibition and mechanisms of drug resistance in mutant FLT3-positive AML-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

FLT3 inhibition and mechanisms of drug resistance in mutant FLT3-positive AML

Published:2009-06 Issue:3 Volume:12 Page:81-89
ISSN:1368-7646
Container-title:Drug Resistance Updates
language:en
Short-container-title:Drug Resistance Updates

Author:

Weisberg Ellen,Barrett Rosemary,Liu Qingsong,Stone Richard,Gray Nathanael,Griffin James D.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Cancer Research,Pharmacology,Oncology

Reference110 articles.

1. Preclinical activity of ABT-869: a multitargeted receptor tyrosine kinase inhibitor;Albert;Mol. Cancer Ther.,2006

2. Heat shock protein 90 inhibition is cytotoxic to primary AML cells expressing mutant FLT3 and results in altered downstream signaling;Al Shaer;Br. J. Haematol.,2008

3. Antitumor activity of sorafenib in FLT3-driven leukemic cells;Auclair;Leukemia,2007

4. Constitutive activation of Akt by Flt3 internal tandem duplications is necessary for increased survival, proliferation, and myeloid transformation;Brandts;Cancer Res.,2005

5. A novel molecular mechanism of primary resistance to FLT3-kinase inhibitors in acute myeloid leukemia;Breitenbuecher;Blood,2009

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Drug Delivery Systems for the Treatment of Acute Myeloid Leukemia;Small;2024-06-27

2. Paclitaxel mediates the PI3K/AKT/mTOR pathway to reduce proliferation of FLT3‑ITD⁺ AML cells and promote apoptosis;Experimental and Therapeutic Medicine;2024-02-23

3. Perspectives and challenges of small molecule inhibitor therapy for FLT3-mutated acute myeloid leukemia;Annals of Hematology;2023-11-17

4. Deciphering the localization and trajectory of human natural killer cell development;Journal of Leukocyte Biology;2023-03-04

5. Loss of MiR-155 Sensitizes FLT3-ITD⁺AML to Chemotherapy and FLT3 Inhibitors via Glycolysis Blocking by Targeting PIK3R1;Journal of Cancer;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3